当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Shulin Song, Changyue Jiang, Donghui Gan, Yibo Lu
Background: This study describes an AIDS patient with CNS tuberculosis and cytomegalovirus infection that experienced IRIS associated with cytomegalovirus encephalitis and PTB while receiving ART.
Case presentation: A 59-year-old male was referred to our hospital with a fever of unknown origin and paroxysmal cough as the main symptoms for three days. CSF examination revealed a cytomegaloviral load of 3.4 ×103 copies/mL and a positive MTB recombination test. CSF gene X-pert MTB/RIF test revealed MTB infection without rifampicin resistance. Anti-tuberculosis treatment and anti-cytomegalovirus therapy were administered, improving clinical and laboratory abnormalities. ART was initiated 24 days after starting anti-tuberculosis treatment, with a baseline CD4+ T lymphocyte count of 70 cells/μL. Clinical symptoms reappeared on day 33 after starting ART. Paradoxical IRIS was considered the most likely diagnosis. After adding dexamethasone to continue antituberculosis and anti-CMV therapy, the patient’s symptoms disappeared, and imaging showed a reduction in scope. There was no recurrence of clinical symptoms during a two-year outpatient follow-up.
Conclusion: It is crucial to consider the emergence of multiple infections and the associated IRIS in AIDS. Once IRIS manifests, proper diagnosis and continual treatment are imperative for patient recovery.